These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1526451)

  • 1. Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability.
    Tzouvelekis LS; Tzelepi E; Mentis AF; Vatopoulos AC; Tsakris A
    FEMS Microbiol Lett; 1992 Aug; 74(2-3):195-9. PubMed ID: 1526451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
    Tzouvelekis LS; Tzelepi E; Kaufmann ME; Mentis AF
    J Med Microbiol; 1994 Jun; 40(6):403-7. PubMed ID: 8006932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.
    Lee EH; Nicolas MH; Kitzis MD; Pialoux G; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1093-8. PubMed ID: 1929248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem resistance in Enterobacter.
    Thomson KS; Sanders CC; Chmel H
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):610-3. PubMed ID: 8223659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.
    Bornet C; Davin-Regli A; Bosi C; Pages JM; Bollet C
    J Clin Microbiol; 2000 Mar; 38(3):1048-52. PubMed ID: 10698994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.
    de Champs C; Henquell C; Guelon D; Sirot D; Gazuy N; Sirot J
    J Clin Microbiol; 1993 Jan; 31(1):123-7. PubMed ID: 8417016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes.
    Hopkins JM; Towner KJ
    J Antimicrob Chemother; 1990 Jan; 25(1):49-55. PubMed ID: 2318754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.
    Raimondi A; Traverso A; Nikaido H
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1174-80. PubMed ID: 1656855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance to imipenem in Enterobacter aerogenes].
    Miró E; Alonso C; Navarro F; Mirelis B; Prats G
    Enferm Infecc Microbiol Clin; 1995 May; 13(5):278-82. PubMed ID: 7779892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.
    Ehrhardt AF; Sanders CC; Thomson KS; Watanakunakorn C; Trujillano-Martin I
    Clin Infect Dis; 1993 Jul; 17(1):120-2. PubMed ID: 8353231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
    Hiraoka M; Inoue M; Mitsuhashi S
    Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic and immunological characterization of a new cephalosporinase from Enterobacter aerogenes.
    Letarte R; Devaud-Felix M; Pechere JC; Allard-Leprohon D
    Antimicrob Agents Chemother; 1977 Aug; 12(2):201-5. PubMed ID: 900918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability.
    Studemeister AE; Quinn JP
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1267-8. PubMed ID: 2461164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa.
    Trias J; Dufresne J; Levesque RC; Nikaido H
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1202-6. PubMed ID: 2508541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter.
    Steffee CH; Wasilauskas BL
    Chemotherapy; 1992; 38(5):291-6. PubMed ID: 1286572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes.
    Thiolas A; Bornet C; Davin-Régli A; Pagès JM; Bollet C
    Biochem Biophys Res Commun; 2004 May; 317(3):851-6. PubMed ID: 15081418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes.
    Chow JW; Shlaes DM
    J Antimicrob Chemother; 1991 Oct; 28(4):499-504. PubMed ID: 1761444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae.
    Yang YJ; Livermore DM; Williams RJ
    J Med Microbiol; 1988 Mar; 25(3):227-33. PubMed ID: 3258037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations.
    Leying H; Cullmann W; Dick W
    Chemotherapy; 1991; 37(2):106-13. PubMed ID: 2032467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of aztreonam and imipenem induction of class I beta-lactamase in Enterobacter cloacae ATCC 13047.
    Gatus BJ; Bell SM; Jimenez AS
    J Antimicrob Chemother; 1989 Dec; 24(6):841-9. PubMed ID: 2621176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.